Key Insights

Highlights

Treatment Research

1 treatments under study, led by Oxymetazoline Hydrochloride

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Recruiting1
Terminated1

Clinical Trials (2)

Showing 2 of 2 trials
NCT02630121Phase 4Recruiting

Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

NCT02710383TerminatedPrimary

Biomarker for Cystic Fibrosis

Showing all 2 trials

Research Network

Common Treatments

  • Oxymetazoline Hydrochloride1

Active Sponsors

  • CENTOGENE GmbH Rostock1
  • University of South Florida1

Top Investigators

Related Conditions

  • Breathlessness1
  • Sleep Apnea1
  • Lung Infection1
  • Clubbing Toes1
  • Meconium Ileus1

Activity Timeline